INS and dementia: Another study found that the proportion of elderly patients with an A1c < 7% who received a prescription for sulfonylurea, insulin or combined insulin and sulfonylurea therapies was 35.2%, 24.2%, and 16.3% respectively and was as prevalent in those with dementia as in those without [8].